GLP-1RAs appear to offer a potential dual therapeutic advantage, simultaneously targeting metabolic dysfunction and immune-mediated inflammation, thereby representing a potentially promising strategy in the management of early-stage PsA early PsA, although robust clinical evidence in this setting is currently lacking
The storage requirements for alternative delivery methods differ from standard vials and pens
C., Montaldo, L., Mela, Q., Mura, M., Astara, G., Tanca, F
Samples were then washed with PBS as described previously and incubated with goat anti-rabbit secondary antibody (1:500 dilution, Beyotime) at room temperature for 1 h in darkness
Supplementary Table 16 (download XLSX The predictions of multi-task neural-network model ensemble for glucagon-like peptide-1 orthologues sequences collected from the NCBI database